Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry

Authors

Nicholas A. Kolaitis, UCSF
Roham T. Zamanian, Stanford University
Vinicio A. de Jesus Perez, Stanford University
David B. Badesch, University of Colorado HSC
Raymond L. Benza, Allegheny General Hospital
Charles D. Burger, Mayo Clinic
Murali M. Chakinala, Washington University
Jean M. Elwing, University of Cincinnati
Jeremy Feldman, LSU Health Science Center - New Orleans
Matthew R. Lammi, LSU Health Science Center - New OrleansFollow
Stephen C. Mathai, Johns Hopkins University
John W. McConnell, Kentuckiana Pulmonary Research Center
Kenneth W. Presberg, Medical College of Wisconsin
Jeffrey C. Robinson, Oregon Clinic
Jeffrey Sager, Cottage Pulmonary Hypertension Center
Oksana A. Shlobin, Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Medical Campus
Marc A. Simon, University of Pittsburgh
Steven M. Kawut, Perelman School of Medicine at the University of Pennsylvania
David V. Glidden, UCSF
Jonathan P. Singer

Document Type

Article

Publication Date

10-15-2020

Publication Title

Annals of the American Thoracic Society

PubMed ID

33064950

Volume

18(4)

Recommended Citation

Kolaitis, Nicholas A.; Zamanian, Roham T.; de Jesus Perez, Vinicio A.; Badesch, David B.; Benza, Raymond L.; Burger, Charles D.; Chakinala, Murali M.; Elwing, Jean M.; Feldman, Jeremy; Lammi, Matthew R.; Mathai, Stephen C.; McConnell, John W.; Presberg, Kenneth W.; Robinson, Jeffrey C.; Sager, Jeffrey; Shlobin, Oksana A.; Simon, Marc A.; Kawut, Steven M.; Glidden, David V.; and Singer, Jonathan P., "Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry" (2020). School of Medicine Faculty Publications. 933.
https://digitalscholar.lsuhsc.edu/som_facpubs/933